Market Overview:
Psoralen is a naturally occurring substance found in certain plants, including figs and celery. Psoralens are used as medications, primarily to treat skin conditions. Psoralen with ultraviolet A (PUVA) therapy is a common treatment for psoriasis. When taken by mouth or applied to the skin before exposure to ultraviolet light, psoralens make the skin more sensitive to UV light.
Product Definition:
Psoralen is a naturally-occurring substance that can be found in certain plants, including figs and celery. When taken orally, psoralen makes the skin more sensitive to ultraviolet light, which can then be used to treat conditions like psoriasis.
More Than 97%:
Psoralen is a naturally occurring organic compound derived from the reaction of psoriasis-causing bacteria with plant materials. Psoralens are used in the treatment of psoriasis and to treat skin cancer. The U.S.
Less Than 97%:
Psoralen is a chemical that occurs naturally in the body as well as can be synthetically produced. Psoralens are used for photodynamic treatment of cancer and other diseases. Photodynamic therapy (PDT) involves the use of psoralens along with light or laser to treat cancer cells which are located in deep within the human body.
Application Insights:
Psoralens are used in the treatment of various skin disorders, such as psoriasis, eczema and acne. The anti-cancer segment held the largest share of over 40% in 2017. Psoralen is widely used for the treatment of different types of cancer including skin cancer and lung cancer. It is primarily used for photodynamic therapy (PDT) application against malignant tumors that do not respond to other forms of therapy.
The research application segment is expected to witness a lucrative CAGR during the forecast period owing to extensive R&D initiatives undertaken by major players in order to develop new applications for psoralens or enhance its current applications. Some key areas where research has shown promising results include phototherapy, photochemotherapy and photobiology which offer potential growth avenues over the coming years.
Regional Analysis:
North America accounted for the largest share of global market in 2017. The region is expected to maintain its position during the forecast period due to presence of major companies involved in manufacturing psoralens and their derivatives. In addition, increasing number of cancer cases has led to an increase in demand for drugs that act by inhibiting photosensitivity reactions caused by ultraviolet light exposure. This factor is anticipated to boost regional growth over the forecast period.
Asia Pacific is expected witness lucrative CAGR over the forecast period owing to rise in disposable income, high population growth rate, and availability of untapped opportunities especially with respect to anti-cancer applications due PsA drug development pipeline (Pipeline). For instance, research conducted on psoralenoids extracted from curcuminoids showed that they exhibited strong inhibitory effect against human breast cancer cell lines (MCF-7) with a concentration dependent manner at concentrations lower than those required for inducing phototoxicity [1].
Growth Factors:
- Increasing incidence of psoriasis: The global psoriasis market is expected to grow at a CAGR of 7.5% from 2016 to 2024, owing to the increasing incidence of psoriasis. Psoralen is used as a treatment for moderate-to-severe cases of the disease and is expected to drive the growth of the market during the forecast period.
- Rising awareness about psoralen: There has been an increase in awareness about psoralen among patients and healthcare professionals in recent years, which is likely to boost demand for this drug in the coming years.
- Growing use of phototherapy with PUVA therapy: Phototherapy with PUVA therapy (psoralen + ultraviolet A) is becoming increasingly popular as a treatment for moderate-to-severe cases of psoriasis, which will spur demand for Psoralen drugs in the coming years.
- Technological advancements: The development and commercialization of novel oral formulations and combination therapies are likely to propel growth prospects for Psoralen market during forecast period 2016–2024 . This will be supported by rising R&D investments by key players operating in this space . 5 Emerging markets offer significant potential growth opportunities: The emerging markets offer significant potential growth opportunities due their large population base and growing prevalence ratesof various skin diseases including psoriasis
Scope Of The Report
Report Attributes
Report Details
Report Title
Psoralen Market Research Report
By Type
More Than 97%, Less Than 97%
By Application
Anti-Cancer, Research
By Companies
BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Ivy Fine Chemicals, Cayman Chemical, Targetmol
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Psoralen Market Report Segments:
The global Psoralen market is segmented on the basis of:
Types
More Than 97%, Less Than 97%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anti-Cancer, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- BLDpharm
- Pharmaffiliates
- ChemScence
- AdooQ BioScience
- ApexBio Technology
- EXTRASYNTHESE
- Merck
- Abcam
- Ivy Fine Chemicals
- Cayman Chemical
- Targetmol
Highlights of The Psoralen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- More Than 97%
- Less Than 97%
- By Application:
- Anti-Cancer
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Psoralen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Psoralen is a medication used to treat psoriasis. It works by blocking the sunlight that triggers the skin disease.
Some of the major companies in the psoralen market are BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Ivy Fine Chemicals, Cayman Chemical, Targetmol.
The psoralen market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Psoralen Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Psoralen Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Psoralen Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Psoralen Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Psoralen Market Size & Forecast, 2020-2028
4.5.1 Psoralen Market Size and Y-o-Y Growth
4.5.2 Psoralen Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 More Than 97%
5.2.2 Less Than 97%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Anti-Cancer
6.2.2 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Psoralen Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Psoralen Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 More Than 97%
9.6.2 Less Than 97%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Anti-Cancer
9.10.2 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 More Than 97%
10.6.2 Less Than 97%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Anti-Cancer
10.10.2 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 More Than 97%
11.6.2 Less Than 97%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Anti-Cancer
11.10.2 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 More Than 97%
12.6.2 Less Than 97%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Anti-Cancer
12.10.2 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 More Than 97%
13.6.2 Less Than 97%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Anti-Cancer
13.10.2 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Psoralen Market: Competitive Dashboard
14.2 Global Psoralen Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 BLDpharm
14.3.3 Pharmaffiliates
14.3.4 ChemScence
14.3.5 AdooQ BioScience
14.3.6 ApexBio Technology
14.3.7 EXTRASYNTHESE
14.3.8 Merck
14.3.9 Abcam
14.3.10 Ivy Fine Chemicals
14.3.11 Cayman Chemical
14.3.12 Targetmol
